Rapt Therapeutics (RAPT)
(Delayed Data from NSDQ)
$2.19 USD
-0.07 (-3.10%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $2.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.58 | 11.76% |
Earnings Summary
For their last quarter, Rapt Therapeutics (RAPT) reported earnings of -$0.71 per share, beating the Zacks Consensus Estimate of $-0.74 per share. This reflects a positive earnings surprise of 4.05%. Look out for RAPT's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.58 per share, reflecting a year-over-year increase of 29.27%.
Earnings History
Price & Consensus
Zacks News for RAPT
Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
RAPT: What are Zacks experts saying now?
Zacks Private Portfolio Services